Nxera Pharma has entered into an exclusive global licensing agreement with AbbVie for NXE0033744, an investigational oral EP4 ...
Transgene and Bispebjerg and Frederiksberg Hospital, University of Copenhagen, have announced that the first patient has been ...
PharmaTimes looks PM Andy Burnham in the eye and asks, what are you going to do for us? We also stare down the ubiquitous AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results